{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:52:57Z","timestamp":1794073977396,"version":"4.8.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01 AA028504"],"award-info":[{"award-number":["R01 AA028504"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.bcp.2023.115613","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T02:20:12Z","timestamp":1684462812000},"page":"115613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Glucagon-like peptide 1 receptor agonist, exendin-4, reduces alcohol-associated fatty liver disease"],"prefix":"10.1016","volume":"213","author":[{"given":"Sundararajan","family":"Mahalingam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Bellamkonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madan Kumar","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathish Kumar","family":"Perumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusum","family":"Kharbanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karuna","family":"Rasineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2023.115613_b0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cld.2018.09.011","article-title":"Epidemiology of Alcohol Consumption and Societal Burden of Alcoholism and Alcoholic Liver Disease","volume":"23","author":"Axley","year":"2019","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.bcp.2023.115613_b0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/tgh.2019.09.08","article-title":"Epidemiology of non-alcoholic and alcoholic fatty liver diseases","volume":"5","author":"Mitra","year":"2020","journal-title":"Transl. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.bcp.2023.115613_b0015","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1111\/acer.14967","article-title":"Role of the ghrelin system in alcohol use disorder and alcohol-associated liver disease: A narrative review","volume":"46","author":"Kharbanda","year":"2022","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"2","key":"10.1016\/j.bcp.2023.115613_b0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jhep.2018.10.023","article-title":"Inflammatory pathways in alcoholic steatohepatitis","volume":"70","author":"Gao","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2023.115613_b0025","series-title":"Alcoholic Liver Disease","author":"Patel","year":"2020"},{"issue":"5","key":"10.1016\/j.bcp.2023.115613_b0030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/acer.12704","article-title":"Alcoholic liver disease: the gut microbiome and liver cross talk","volume":"39","author":"Hartmann","year":"2015","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"10","key":"10.1016\/j.bcp.2023.115613_b0035","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/biom9100517","article-title":"Inhibition of Ghrelin Activity by Receptor Antagonist [d-Lys-3] GHRP-6 Attenuates Alcohol-Induced Hepatic Steatosis by Regulating Hepatic Lipid Metabolism","volume":"9","author":"Rasineni","year":"2019","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.bcp.2023.115613_b0040","doi-asserted-by":"crossref","first-page":"G453","DOI":"10.1152\/ajpgi.00334.2018","article-title":"Chronic alcohol exposure alters circulating insulin and ghrelin levels: role of ghrelin in hepatic steatosis","volume":"316","author":"Rasineni","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115613_b0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nrgastro.2017.116","article-title":"Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations","volume":"15","author":"Parker","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2023.115613_b0050","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"Muller","year":"2019","journal-title":"Mol. Metab."},{"issue":"6","key":"10.1016\/j.bcp.2023.115613_b0055","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.molmet.2015.03.005","article-title":"Ghrelin","volume":"4","author":"Muller","year":"2015","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bcp.2023.115613_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146562","article-title":"Alcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1","volume":"1727","author":"Jerlhag","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2023.115613_b0065","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1038\/tp.2015.68","article-title":"The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependence","volume":"5","author":"Suchankova","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bcp.2023.115613_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.599646","article-title":"Long-Acting Glucagon-Like Peptide-1 Receptor Agonists Suppress Voluntary Alcohol Intake in Male Wistar Rats","volume":"14","author":"Marty","year":"2020","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115613_b0075","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1038\/s41598-022-17190-3","article-title":"Differential association between the GLP1R gene variants and brain functional connectivity according to the severity of alcohol use","volume":"12","author":"Farokhnia","year":"2022","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.bcp.2023.115613_b0080","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.3390\/cancers14194651","article-title":"How Far beyond Diabetes Can the Benefits of Glucagon-like Peptide-1 Receptor Agonists Go? A Review of the Evidence on Their Effects on Hepatocellular Carcinoma","volume":"14","author":"Arvanitakis","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bcp.2023.115613_b0085","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115613_b0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.21006","article-title":"Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob\/ob mice","volume":"43","author":"Ding","year":"2006","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bcp.2023.115613_b0095","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/metabo11020073","article-title":"Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials","volume":"11","author":"Mantovani","year":"2021","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.bcp.2023.115613_b0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/clinem\/dgab578","article-title":"The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD","volume":"107","author":"Patel Chavez","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bcp.2023.115613_b0105","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2337\/ds16-0026","article-title":"Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes","volume":"30","author":"Hinnen","year":"2017","journal-title":"Diabetes Spectr."},{"issue":"2","key":"10.1016\/j.bcp.2023.115613_b0110","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2015.08.038","article-title":"Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis","volume":"64","author":"Armstrong","year":"2016","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.bcp.2023.115613_b0115","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.2337\/diabetes.52.9.2315","article-title":"An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures","volume":"52","author":"Bennett","year":"2003","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.bcp.2023.115613_b0120","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/en.2003-1099","article-title":"Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells","volume":"145","author":"Merglen","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2023.115613_b0125","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/954157","article-title":"Cyanamide potentiates the ethanol-induced impairment of receptor-mediated endocytosis in a recombinant hepatic cell line expressing alcohol dehydrogenase activity","volume":"2012","author":"Clemens","year":"2012","journal-title":"Int. J. Hepatol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115613_b0130","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/hep4.1063","article-title":"Ethanol-induced steatosis involves impairment of lipophagy, associated with reduced Dynamin2 activity","volume":"1","author":"Rasineni","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.bcp.2023.115613_b0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12876-016-0433-4","article-title":"Alcoholic vs non-alcoholic fatty liver in rats: distinct differences in endocytosis and vesicle trafficking despite similar pathology","volume":"16","author":"Rasineni","year":"2016","journal-title":"BMC Gastroenterol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115613_b0140","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00125-010-2028-x","article-title":"Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes","volume":"54","author":"Kodera","year":"2011","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.bcp.2023.115613_b0145","doi-asserted-by":"crossref","first-page":"e31394","DOI":"10.1371\/journal.pone.0031394","article-title":"Exendin-4 improves steatohepatitis by increasing Sirt1 expression in high-fat diet-induced obese C57BL\/6J mice","volume":"7","author":"Lee","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bcp.2023.115613_b0150","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1210\/endo.141.6.7490","article-title":"Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats","volume":"141","author":"Szayna","year":"2000","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115613_b0155","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1055\/s-2007-993218","article-title":"Prevention of insulin resistance by ingesting aqueous extract of Ocimum sanctum to fructose-fed rats","volume":"40","author":"Reddy","year":"2008","journal-title":"Horm. Metab. Res."},{"issue":"1","key":"10.1016\/j.bcp.2023.115613_b0160","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2023.115613_b0165","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/acer.12271","article-title":"Rab GTPases associate with isolated lipid droplets (LDs) and show altered content after ethanol administration: potential role in alcohol-impaired LD metabolism","volume":"38","author":"Rasineni","year":"2014","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"3","key":"10.1016\/j.bcp.2023.115613_b0170","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ajpath.2011.11.017","article-title":"Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis","volume":"180","author":"Zhong","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"12","key":"10.1016\/j.bcp.2023.115613_b0175","doi-asserted-by":"crossref","first-page":"e5826","DOI":"10.1590\/1414-431x20165826","article-title":"Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages","volume":"49","author":"Guo","year":"2016","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.bcp.2023.115613_b0180","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/524517","article-title":"The GLP-1 analogue exenatide improves hepatic and muscle insulin sensitivity in diabetic rats: tracer studies in the basal state and during hyperinsulinemic-euglycemic clamp","volume":"2014","author":"Wu","year":"2014","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.bcp.2023.115613_b0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/DMSO.S48260","article-title":"Akt\/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes","volume":"7","author":"Mackenzie","year":"2014","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.bcp.2023.115613_b0190","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2147\/DMSO.S250699","article-title":"Anti-Lipolysis Induced by Insulin in Diverse Pathophysiologic Conditions of Adipose Tissue","volume":"13","author":"Zhao","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"9","key":"10.1016\/j.bcp.2023.115613_b0195","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1530-0277.2007.00452.x","article-title":"Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines","volume":"31","author":"Kang","year":"2007","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"4","key":"10.1016\/j.bcp.2023.115613_b0200","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/biom7010016","article-title":"Alcohol, Adipose Tissue and Lipid Dysregulation","volume":"7","author":"Steiner","year":"2017","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bcp.2023.115613_b0205","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1038\/s41598-017-06951-0","article-title":"Exendin-4 reduces food intake via the PI3K\/AKT signaling pathway in the hypothalamus","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2023.115613_b0210","doi-asserted-by":"crossref","first-page":"E287","DOI":"10.1152\/ajpendo.00440.2004","article-title":"PPARgamma-mediated insulin sensitization: the importance of fat versus muscle","volume":"288","author":"Kintscher","year":"2005","journal-title":"Am. J. Phys. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2023.115613_b0215","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1463-1326.2012.01663.x","article-title":"GLP-1 receptor activated insulin secretion from pancreatic beta-cells: mechanism and glucose dependence","volume":"15","author":"Meloni","year":"2013","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bcp.2023.115613_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol. Metab."},{"issue":"4","key":"10.1016\/j.bcp.2023.115613_b0225","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/hep4.1322","article-title":"Serum Metabolomic Profiling Identifies Key Metabolic Signatures Associated With Pathogenesis of Alcoholic Liver Disease in Humans","volume":"3","author":"Yang","year":"2019","journal-title":"Hepatol. Commun."},{"issue":"2","key":"10.1016\/j.bcp.2023.115613_b0230","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2337\/diaclin.34.2.97","article-title":"Treatment Approach to Patients With Severe Insulin Resistance","volume":"34","author":"Church","year":"2016","journal-title":"Clin. Diabetes"},{"issue":"9","key":"10.1016\/j.bcp.2023.115613_b0235","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1210\/jc.2011-0255","article-title":"Approach to the hospitalized patient with severe insulin resistance","volume":"96","author":"Larsen","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2023.115613_b0240","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/5584_2020_496","article-title":"Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity","volume":"1307","author":"Maselli","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115613_b0245","doi-asserted-by":"crossref","first-page":"1418593","DOI":"10.1080\/20010001.2017.1418593","article-title":"Exendin-4 protects mice from D-galactose-induced hepatic and pancreatic dysfunction","volume":"8","author":"Ahangarpour","year":"2018","journal-title":"Pathobiol. Aging Age Relat. Dis."},{"issue":"1","key":"10.1016\/j.bcp.2023.115613_b0250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2337\/db05-0996","article-title":"Exendin-4 potently decreases ghrelin levels in fasting rats","volume":"56","author":"Perez-Tilve","year":"2007","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.bcp.2023.115613_b0255","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bbrc.2009.10.015","article-title":"Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression","volume":"390","author":"Kim Chung","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.bcp.2023.115613_b0260","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1194\/jlr.M056978","article-title":"Ethanol-induced hepatic steatosis is modulated by glycogen level in the liver","volume":"56","author":"Gu","year":"2015","journal-title":"J. Lipid Res."},{"issue":"6865","key":"10.1016\/j.bcp.2023.115613_b0265","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bcp.2023.115613_b0270","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1074\/jbc.M111.310342","article-title":"Regulation of adipocyte formation by GLP-1\/GLP-1R signaling","volume":"287","author":"Challa","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2023.115613_b0275","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0092-8674(00)81654-2","article-title":"PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function","volume":"99","author":"Lowell","year":"1999","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2023.115613_b0280","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12020-007-9011-4","article-title":"GLP-1 amplifies insulin signaling by up-regulation of IRbeta, IRS-1 and Glut4 in 3T3-L1 adipocytes","volume":"32","author":"Gao","year":"2007","journal-title":"Endocrine"},{"issue":"10","key":"10.1016\/j.bcp.2023.115613_b0285","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.2337\/db14-0302","article-title":"GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK","volume":"63","author":"Beiroa","year":"2014","journal-title":"Diabetes"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223002046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223002046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:45:57Z","timestamp":1757771157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223002046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":57,"alternative-id":["S0006295223002046"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115613","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like peptide 1 receptor agonist, exendin-4, reduces alcohol-associated fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115613"}}